Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer
A Randomized Study to Investigate the Presence of Tocopherol Metabolites in the Prostate
Status: Archived
University of Medicine and Dentistry - Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer
A Randomized Study to Investigate the Presence of Tocopherol Metabolites in the Prostate
Status: Archived
Updated: 1/1/1970
University of Medicine and Dentistry - Robert Wood Johnson University Hospital
mi
from
New Brunswick, NJ
Effect of Rifampin on the Pharmacokinetics of BAY73-4506
A Phase 1, Non-Randomized, Open Label Study to Determine the Effect of Rifampin on the Pharmacokinetics of a Single Oral Dose of 160 mg Regorafenib (BAY73-4506) in Healthy Volunteers
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
Effect of Rifampin on the Pharmacokinetics of BAY73-4506
A Phase 1, Non-Randomized, Open Label Study to Determine the Effect of Rifampin on the Pharmacokinetics of a Single Oral Dose of 160 mg Regorafenib (BAY73-4506) in Healthy Volunteers
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer
Status: Archived
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer
Status: Archived
Updated: 1/1/1970
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Effect of Ketoconazole on Regorafenib (BAY73-4506) Pharmacokinetics
A Phase I, Non-Randomized, Open Label Study to Determine the Effetc of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of Regorafenib (BAY73-4506) in Healthy Volunteers
Status: Archived
Clinical Trial Facility
mi
from
Boston, MA
Effect of Ketoconazole on Regorafenib (BAY73-4506) Pharmacokinetics
A Phase I, Non-Randomized, Open Label Study to Determine the Effetc of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of Regorafenib (BAY73-4506) in Healthy Volunteers
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Boston, MA
Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)
International Randomized Study of Transarterial Chemoembolization Versus CyberKnife® for Recurrent Hepatocellular Carcinoma
Status: Archived
Stanford Clinical Research Center
mi
from
Stanford, CA
Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)
International Randomized Study of Transarterial Chemoembolization Versus CyberKnife® for Recurrent Hepatocellular Carcinoma
Status: Archived
Updated: 1/1/1970
Stanford Clinical Research Center
mi
from
Stanford, CA
Seamless Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable Patients
Seamless Phase I/II Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable Patients
Status: Archived
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Seamless Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable Patients
Seamless Phase I/II Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable Patients
Status: Archived
Updated: 1/1/1970
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
GSK Investigational Site
mi
from
Indianapolis, IN
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Indianapolis, IN
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
GSK Investigational Site
mi
from
Westwood, KA
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Westwood, KA
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
GSK Investigational Site
mi
from
Chesterfield, MO
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Chesterfield, MO
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
GSK Investigational Site
mi
from
Las Vegas, NV
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Las Vegas, NV
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Updated: 1/1/1970
West Virginia University Hospitals Inc.
mi
from
Morgantown, WV
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
GSK Investigational Site
mi
from
Austin, TX
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Austin, TX
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
GSK Investigational Site
mi
from
Kennewick, WA
A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population
A Randomized, Open-label, Phase II, 2-arm Multi-center Trial Comparing Maintenance Therapy With Pazopanib or Pemetrexed in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) After Induction Therapy With Carboplatin or Cisplatin Plus Pemetrexed
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Kennewick, WA
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
Pilot Project for Anal Dysplasia Screening in Women With Cervical or Vulvar Dysplasia
Status: Archived
Northwestern University
mi
from
Chicago, IL
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
Pilot Project for Anal Dysplasia Screening in Women With Cervical or Vulvar Dysplasia
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer
GE148-002: A Phase 2, Open-label, Single-Center, Study to Assess GE-148 (18F) Injection Positron Emission Tomography(PET) Imaging to Detect Localized Prostate Cancer
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer
GE148-002: A Phase 2, Open-label, Single-Center, Study to Assess GE-148 (18F) Injection Positron Emission Tomography(PET) Imaging to Detect Localized Prostate Cancer
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
A Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy
A PHASE III TRIAL OF SHORT TERM ANDROGEN DEPRIVATION WITH PELVIC LYMPH NODE OR PROSTATE BED ONLY RADIOTHERAPY (SPPORT) IN PROSTATE CANCER PATIENTS WITH A RISING PSA AFTER RADICAL PROSTATECTOMY
Status: Archived
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
A Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy
A PHASE III TRIAL OF SHORT TERM ANDROGEN DEPRIVATION WITH PELVIC LYMPH NODE OR PROSTATE BED ONLY RADIOTHERAPY (SPPORT) IN PROSTATE CANCER PATIENTS WITH A RISING PSA AFTER RADICAL PROSTATECTOMY
Status: Archived
Updated: 1/1/1970
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
A Phase II, 2-Stage, 2-Arm PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
Status: Archived
Dana-Farber Cancer Institute
mi
from
Boston, MA
PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
A Phase II, 2-Stage, 2-Arm PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
Status: Archived
Updated: 1/1/1970
Dana-Farber Cancer Institute
mi
from
Boston, MA
PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
A Phase II, 2-Stage, 2-Arm PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
A Phase II, 2-Stage, 2-Arm PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab
Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab
Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids
Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids
Status: Archived
Meharry Medical College
mi
from
Nashville, TN
Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids
Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids
Status: Archived
Updated: 1/1/1970
Meharry Medical College
mi
from
Nashville, TN
A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
A Phase 2, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of IPI-926 in Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
Status: Archived
(TGen) Translational Genomics Research Institute
mi
from
Scottsdale, AZ
A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
A Phase 2, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of IPI-926 in Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma
Status: Archived
Updated: 1/1/1970
(TGen) Translational Genomics Research Institute
mi
from
Scottsdale, AZ
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
University of Alabama - Burmingham
mi
from
Birmingham, AL
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
University of Alabama - Burmingham
mi
from
Birmingham, AL
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Georgia Clinical Research
mi
from
Austell, GA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
Georgia Clinical Research
mi
from
Austell, GA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Indiana University
mi
from
Indianapolis, IN
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
Indiana University
mi
from
Indianapolis, IN
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Louisiana State University
mi
from
New Orleans, LA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
Louisiana State University
mi
from
New Orleans, LA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
University of Missouri
mi
from
Columbia, MO
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
University of Missouri
mi
from
Columbia, MO
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
New York University
mi
from
New York, NY
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
New York University
mi
from
New York, NY
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Temple University
mi
from
Philadelphia, PA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
Temple University
mi
from
Philadelphia, PA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Vanderbilt University Medical Center
mi
from
Ventura, CA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Ventura, CA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
University of Virginia
mi
from
Charlottesville, VA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: CLIA
Status: Archived
Updated: 1/1/1970
University of Virginia
mi
from
Charlottesville, VA
Apollo Overstitch, a Treat and Resect Model
Evaluation of a Novel Endoscopic Suturing Device in a Treat and Resect Model
Status: Archived
Case Western Reserve Univ
mi
from
Cleveland, OH
Apollo Overstitch, a Treat and Resect Model
Evaluation of a Novel Endoscopic Suturing Device in a Treat and Resect Model
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
A Phase 2 and Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
Status: Archived
Coastal Bend Cancer Center
mi
from
Corpus Christi, TX
A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
A Phase 2 and Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
Status: Archived
Updated: 1/1/1970
Coastal Bend Cancer Center
mi
from
Corpus Christi, TX
Study of EZN-2208 Pediatric Patients With Solid Tumors
A Phase 1/2 Study of EZN-2208 in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors
Status: Archived
Lia Gore, MD
mi
from
Aurora, CO
Study of EZN-2208 Pediatric Patients With Solid Tumors
A Phase 1/2 Study of EZN-2208 in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Lia Gore, MD
mi
from
Aurora, CO
Study of EZN-2208 Pediatric Patients With Solid Tumors
A Phase 1/2 Study of EZN-2208 in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors
Status: Archived
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Study of EZN-2208 Pediatric Patients With Solid Tumors
A Phase 1/2 Study of EZN-2208 in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Status: Archived
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Status: Archived
Updated: 1/1/1970
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Phase I Study of GC1008 in Patients With Primary Myelofibrosis (PMF), Post-polycythemia Vera/Essential Thrombocythemia Related Myelofibrosis (Post-PV/ET MF)
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
Status: Archived
Georgetown Univ Med Ctr
mi
from
Washington,
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
Status: Archived
Updated: 1/1/1970
Georgetown Univ Med Ctr
mi
from
Washington,
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
Status: Archived
Temple University
mi
from
Philadelphia, PA
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
Status: Archived
Updated: 1/1/1970
Temple University
mi
from
Philadelphia, PA
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
Status: Archived
City of Hope Medical Canter
mi
from
Duarte, CA
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
Status: Archived
Updated: 1/1/1970
City of Hope Medical Canter
mi
from
Duarte, CA
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
Development and Implementation of a Patient-reported Outcome Questionnaire to Assess the Value of Progression-free Survival for Women With Metastatic Breast Cancer.
Status: Archived
Health Outcomes Solutions
mi
from
Winter Park, FL
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
Development and Implementation of a Patient-reported Outcome Questionnaire to Assess the Value of Progression-free Survival for Women With Metastatic Breast Cancer.
Status: Archived
Updated: 1/1/1970
Health Outcomes Solutions
mi
from
Winter Park, FL
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and With Normal Renal Function
Status: Archived
Indiana University Melvin and Bren Simon Cancer Center, Hematology/Oncology Dept.
mi
from
Indiannapolis, IN
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and With Normal Renal Function
Status: Archived
Updated: 1/1/1970
Indiana University Melvin and Bren Simon Cancer Center, Hematology/Oncology Dept.
mi
from
Indiannapolis, IN
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and With Normal Renal Function
Status: Archived
Hematology /Oncology Associates
mi
from
Rockville, MD
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and With Normal Renal Function
Status: Archived
Updated: 1/1/1970
Hematology /Oncology Associates
mi
from
Rockville, MD
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and With Normal Renal Function
Status: Archived
Josephine Ford Cancer Center at Henry Ford Hospital
mi
from
Detroit, MI
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and With Normal Renal Function
Status: Archived
Updated: 1/1/1970
Josephine Ford Cancer Center at Henry Ford Hospital
mi
from
Detroit, MI
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and With Normal Renal Function
Status: Archived
Seattle Cancer Care Alliance
mi
from
Seattle, WA
A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function
A Multi-center, Open-label, Dose-escalation Study to Assess the Pharmacokinetics of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and With Normal Renal Function
Status: Archived
Updated: 1/1/1970
Seattle Cancer Care Alliance
mi
from
Seattle, WA